A：Ecolab's adjusted EPS growth of 11% in the second quarter was driven by accelerating organic sales growth of 5%, stable organic gross margin, and continued strong productivity.

A：Ecolab addressed the impact of rising commodity costs by implementing a global energy surcharge, which helped to offset the impact on margins and EPS. As a result, pricing strengthened, and the company expects the second half to be within its targeted NGS range.

A：Ecolab's global team absorbed increasing commodity costs, won new business, grew volumes, stabilized organic gross margin, and delivered double-digit EPS growth during the transition period. The team also saw momentum strengthen across the portfolio.

A：Despite a nearly 1% headwind from customer operations disrupted by the conflict in the Middle East, Ecolab's volumes grew 1%. Excluding this disruption, line volume growth accelerated from the first quarter, and growth in core businesses strengthened.

A：Ecolab completed the acquisition of Kuol Light Systems in July. The Global High Tech segment grew 29%, reflecting strong demand across microelectronics and data centers. It achieved nearly $1.5 billion in annualized sales and closed the acquisition with year-to-date sales growth exceeding 100%.

A：The Water segment grew 27% driven by the adoption of software and connected solutions. The Digital segment grew 27% on strong adoption of its offerings. The Life Sciences segment accelerated to 15% growth, gaining market share in bioprocessing, pharma, and personal care, with particularly strong performance in purification.

A：The Global High Tech platform is now expected to grow more than 20% annually, reaching $4 billion in sales by 2030 with an operating income margin of 25%, reflecting the business's acceleration and growth expectations.

A：Ecolab's core businesses, representing 70% of sales, grew low single digits with Oi margins just above 20%. The growth engines, which account for about 15% of sales, grew in the low teens with Oi margins nearing 20%. Underperforming businesses, comprising 15% of sales, experienced low single-digit declines and stable performance with Oi margins in the mid-teens.

A：For 2027, Ecolab expects continued momentum in pricing and volumes, leading to organic sales growth and adjusted operating income margin. The company plans to achieve its 20% operating margin target through strong underlying performance and the short-term impact from non-cash amortization and financing costs from the Kool It acquisition.

A：Ecolab intends to offset the extra incremental expenses related to the acquisition of Kool It by achieving strong underlying performance and managing the short-term impact from non-cash amortization and financing costs. This strategy aligns with the company's trajectory to maintain and improve its operating income margins and EPS growth.

A：The company's commitment is to deliver a 20% operating income (Oi) margin by 2027. They expect to achieve 5 to 7% organic sales growth and 12 to 15% earnings per share growth. The adjusted Oi margin for the second half of the year is expected to be 19%, contributing to the 2027 goal. The company aims to not only meet but exceed these commitments, with most businesses already close to or above a 20% Oi margin.

A：The business is roughly split between data centers and microelectronics, each generating about $500 million in annualized sales. Additionally, the life sciences business contributes another $500 million. The company has built a platform rapidly over the last few years, with all three elements (legacy, microelectronics, and data centers) growing strongly. They expect to reach the $1 billion target and project a 25% growth trajectory over the next few years, leading to a $4 billion annual sales run rate by 2030.

A：The company expects a very good trajectory of 25% growth for the next few years, which is led by their legacy business expected to grow 29%, and Kulat and ODI contributing with mid-teens and north of 100% growth respectively. This growth is anticipated to lead to a 4 billion annual sales run rate by 2030. They feel confident that achieving this growth is realistic.

A：The integrated end-to-end cooling platform that the company plans to launch at the SuperCompute event will help drive more cross-selling opportunities by multiplying the sales opportunity with the addition of CoolIt's technology in the data center by 3 to 5 times compared to legacy Ecolab solutions. This platform includes integrated 3D tracer control technology, 3D tracer coolant, and cold plates that optimize the entire system to reduce power used for cooling while using zero net incremental water. This is expected to significantly benefit customers, especially in the context of growing AI infrastructure and data centers.

A：The integration of the 3D tracer technology in the next generation of the CD has been accomplished in just two weeks, which is a good example of how the teams from the company and CoolIt have come together. This rapid integration demonstrates the companies' ability to quickly combine technologies to enhance their cooling solutions.

A：The acquisition of PureLight in 2021 has been beneficial, as the life sciences team has built capacity, capabilities, relationships with customers, and trust, positioning the company to be a top partner in the future. Despite Covid's challenges, the team has performed well, growing when the rest of the industry was not. The business has been outperforming the market and competition and is back in line with the initial return expectations set for the process. The company is particularly pleased with the agility, innovation, and entrepreneurial spirit of their team in meeting customers' short-term needs to deliver life-saving drugs.

A：Post-acquiring CoolIt, the company's growth trajectory for the combined business is estimated to be around 30% annually. While it's still early days with the teams only having worked together for a few weeks, the first half of the year has been much better than expected, with customer acceptance of CoolIt's latest technologies being extremely good. The company plans to gather more data and refine the trajectory over the next few months, with an update scheduled for November at SuperCompute.

A：The trajectory has been affected by ramps of andes, with the business initially starting off in larger scale in Europe. Investments in leeway with partners in the United States have been made to increase the probability of sustaining this type of growth.

A：The life sciences business has been on the high end of expected performance for several quarters. Early years showed faster growth than the industry but not as fast as expected. Investments were made to build capabilities around the world, including opening a plant in China. The business is growing around Asia, Europe, and is almost expanding to all three continents.

A：The pharma personal care business, which focuses on contamination control and ensuring a healthy environment for drug production, is doing extremely well.

A：The long-term target is to reach an EBITDA margin of 12%, which is currently being exceeded. The business is ahead of the range in terms of margins and is on track to reach the 30% or target, with a clear line of sight to achieving it.

A：The strategy in the old economy sectors is to continue to invest in research, innovation, and science, which are crucial for the company's customers and success. The focus is on traditional businesses which, while not expected to grow as much as the growth engines, are performing better and gaining share.

A：The paper industry is facing challenges due to consolidation and losing paper mills, which has impacted sales. However, the last six months have seen a halt in industry consolidation, and the company is gaining market share, performing slightly better than the industry, and is cautiously optimistic about future prospects.

A：The bioprocessing business has a strong competitive position across early stages, clinical trials, and commercial drugs. The team has performed well in securing the entire spectrum, with investments ahead of growth to ensure the business maintains a strong position and can accelerate future growth.

A：The company does not have the ambition to become the biggest in the industry, but rather aims to become the best life sciences business. Investments have been made to ensure the business grows at a sustainable and accelerated rate, with underlying margins improving.

A：The company plans to continue investing ahead of growth, particularly in high-tech businesses like life science and water treatment. The growth in the high-tech business is faster than originally anticipated, which may require adjusting the investment pace. CapEx for the company is expected to remain around the current levels for the next couple of years.

A：The increased traction in Ecolab's food and beverage business is attributed to the Ecolab approach, where the team has integrated food safety and water expertise into one organization. This has led to a strategic approach to producing safe food with reduced water and energy usage, as well as a focus on cross-selling solutions.

A：The main drivers behind the growth are the integration of food safety and water solutions and the strategic cross-selling of these solutions into each other's customer bases, along with executing a good strategic intent.

A：Ecolab is expanding its successful North American model internationally, which involves integrating its food safety and water teams to serve customers globally. This expansion is expected to take time but will drive momentum for the years to come.

A：The '100 modeled Eric' internal initiative is significant for Ecolab as it aims to connect 100% of customer locations, 100% of applications within those customer locations, and generate revenue from them. This initiative could drive potential revenue of 3 billion dollars within the current customer base, and reaching this goal is a priority for the company.

A：Ecolab's current volume growth trajectory is estimated to be around 1% for the next few quarters. The company is experiencing challenges, particularly in the Middle East, which is impacting their ability to achieve higher growth rates. However, Ecolab expects this trajectory to improve over time and to remain steady at 1% or slightly above.

A：Ecolab is managing the energy surcharge and pricing by focusing on value pricing, which has resulted in a shift towards structural pricing within a three-month period. This approach has not only been effective in aligning costs and revenue but has also maintained customer retention, indicating the right pricing strategy. Ecolab expects to achieve positive gross organic gross margin in the second half due to the expertise of their team and the effectiveness of their pricing strategy.

A：The targeted growth trajectory is 6 to 8%, with a current status of being in the middle of the target range at 7%. The focus is on delivering on this promise and then improving further.

A：Investments are being made in new technologies and innovations to create the right foundations for future benefits. These include an increase in the number of connected devices, expected to exceed 1 million by the end of the year, which is a unique position compared to other companies globally. This requires effort and investments, but it is anticipated to yield both top-line and bottom-line improvements due to the business having high margins and returns.

A：The specific question regarding return on capital, assets, or equity in comparison to Ecolab's performance before acquisitions was not directly answered. However, it was mentioned that the focus is on ROIC and that the company aims to grow and maintain a strong return profile, with specific investment returns being well above the cost of capital. It was also mentioned that while there might be short-term dilutive impacts due to acquisitions, the goal is to return to pre-acquisition levels of organic ROIC by 2028.

A：The current expectation for the life sciences business is that it is back on track to meet the early promised return. The team focused on getting the business back on this track and is taking it seriously.

A：The operating leverage is not expanding more materially due to the challenges in protecting gross margins, especially in a service and technology business. The need to double the price versus the cost while maintaining service quality and growth in three months is an accomplishment that's difficult to achieve. Also, the strategy involves ensuring customers receive savings higher than the incremental price they pay, which benefits the gross margin over time.

A：Current commodity prices are expected to remain high, which could impact margins. Additionally, the acquisition of Vivo has contributed to a reported gross margin drag of 60 basis points, which may also factor into the overall margins. The guidance provided is reflective of the current situation and not just past assumptions.

A：The confidence to raise 2030 expectations significantly prior to July was based on a few things, but specific details were not provided. However, the expectation to discuss the impact of the acquisition of Cool It on future expectations was mentioned as being potentially addressed in a few months, indicating a positive outlook related to the acquisition's integration and performance.

A：The trajectory of the businesses is on an upward path, with core business doing particularly well in the second quarter. The investor day in November is to reflect on the businesses' position in light of market movements and technological leadership, which is expected to be better than initially planned.

A：The outbreak has influenced consumer behavior and impacted restaurant customers' foot traffic. Ecolab anticipates that these events, while not changing consumption or demand, lead customers to invest more time in research and development with Ecolab's team to understand and address the issues, which is beneficial for Ecolab's business.

A：Ecolab's business has seen customers seeking their expertise in infection prevention and spending time with Ecolab's R&D team to understand and solve the issues. Ecolab has been closely involved with restaurants, staying behind the scenes to help but not taking the forefront in media matters. The company views the outbreak as an opportunity to connect with end-users and position itself to benefit from the resulting heightened awareness of hygiene and infection prevention.

A：The potential business opportunity for Ecolab is to connect end-users, like restaurants and retailers, directly with the producers who implement Ecolab's solutions. This business model is new and leverages Ecolab's position of protecting a third of the world's production and serving a wider array of end-users, retail, restaurants, and hotels.

A：The industry reaction to the 50 kW cold plate announced by Cool Lamp Siege has been very positive. The market is anticipating the technology and is looking for the latest updates, which has resulted in a situation where demand management is needed more than supply, representing a significant shift in the market dynamic.

A：Ecolab feels good about the trajectory for the remainder of the year and is clear through to the end of December. The company projects a 30% growth rate for the next decade and plans to share more detailed guidance at their investor meeting in November. In terms of market approach, Ecolab's model works closely with chip designers and manufacturers and hyperscalers, which is a strength of the business and contributes to the visibility into the order backlog and pipeline.